Trial 0C-16-7


An Open-label, Dose-finding and Proof of Concept Study for Probody™ therapeutics (probody tx) in Subjects with Metastatic or Locally Advanced Unresectable Solid Tumors and/or Lymphomas

Type: Treatment
Phase: Phase I/II
Status: Not Open (Closed)
Treatments: Immunotherapy, Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Yan Ning, D.M., Vage Movsesyan, D.M., Lorraine Martinez, Coordinator, Rishi Bhavsar, Coordinator, Anayansi Miloud, D.M., Xiomara Menendez, Coordinator, Jessica Levano, R.N., Taison Tran, Coordinator, Jubilee Acap, R.N., Khatchik Karakozian, D.M., Kseniia Kulakova, D.M., Cristina Lee, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.